使用锝-99m进行甲状腺功能的常规评估。
Use of 99 Tc m for the routine assessment of thyroid function.
作者信息
Goolden A W, Glass H I, Williams E D
出版信息
Br Med J. 1971 Nov 13;4(5784):396-9. doi: 10.1136/bmj.4.5784.396.
Abstract
(99)Tc(m)-pertechnetate is concentrated in the thyroid in the same way as iodide but it does not become organically bound. The uptake of (99)Tc(m) is a measure of the thyroid trap, and this measurement is satisfactory as a routine test in the diagnosis of thyrotoxicosis. The reproducibility of the method is such that suppression tests can be carried out when necessary even when uptake is within the normal range of 0.4-3%. (99)Tc(m) gives a low radiation dose to the thyroid and has certain other advantages over radioactive isotopes of iodine for early thyroid uptake measurements. It is particularly suitable when serial tests of thyroid function are required during treatment with an antithyroid drug.
摘要
（99）锝-高锝酸盐与碘化物一样在甲状腺中浓聚，但它不会与甲状腺组织有机结合。（99）锝的摄取是甲状腺摄取功能的一种衡量指标，作为甲状腺毒症诊断的常规检查，这种测量结果令人满意。该方法的可重复性使得即使摄取率在正常范围0.4%-3%之内，必要时也可进行抑制试验。（99）锝对甲状腺的辐射剂量较低，与碘的放射性同位素相比，在早期甲状腺摄取测量方面还有其他一些优势。在使用抗甲状腺药物治疗期间需要对甲状腺功能进行系列检查时，它特别适用。
相似文献
1
Use of 99 Tc m for the routine assessment of thyroid function.使用锝-99m进行甲状腺功能的常规评估。
Br Med J. 1971 Nov 13;4(5784):396-9. doi: 10.1136/bmj.4.5784.396.
2
Technetium uptake in the management of thyrotoxicosis.锝摄取在甲状腺毒症治疗中的应用。
Clin Endocrinol (Oxf). 1978 Apr;8(4):327-33. doi: 10.1111/j.1365-2265.1978.tb02775.x.
3
Thyroidal suppressibility after stopping long-term treatment of thyrotoxicosis with anti-thyroid drugs.停用抗甲状腺药物长期治疗甲状腺毒症后的甲状腺抑制性
Metabolism. 1969 Jan;18(1):58-62. doi: 10.1016/0026-0495(69)90133-4.
4
The diagnostic and prognostic value of the 20 min 99mTc-uptake in the thyroid gland.甲状腺20分钟99mTc摄取的诊断和预后价值。
Acta Endocrinol (Copenh). 1973 Dec;74(4):659-65. doi: 10.1530/acta.0.0740659.
5
Technetium-99 m in the diagnosis of thyrotoxicosis.锝-99m在甲状腺毒症诊断中的应用
Br Med J. 1972 Oct 28;4(5834):203-6. doi: 10.1136/bmj.4.5834.203.
6
Iodine organification defect following treatment of thyrotoxicosis with antithyroid drugs.抗甲状腺药物治疗甲状腺毒症后碘有机化缺陷。
Clin Endocrinol (Oxf). 1975 Jul;4(4):357-62. doi: 10.1111/j.1365-2265.1975.tb01544.x.
7
The variation in serum triiodothyronine (T3) achieved during suppression testing in thyrotoxicosis.甲状腺毒症抑制试验期间血清三碘甲状腺原氨酸（T3）的变化。
Clin Endocrinol (Oxf). 1978 Dec;9(6):549-55. doi: 10.1111/j.1365-2265.1978.tb01513.x.
8
A comparison between the uptake of technetium-99m and iodine-131 by the thyroid gland.甲状腺对锝-99m和碘-131摄取的比较。
J Endocrinol. 1971 Mar;49(3):531-6. doi: 10.1677/joe.0.0490531.
9
Measurements of the radioactive iodide and pertechnetate uptake for the study of the trapping and binding functions of the human thyroid.用于研究人体甲状腺摄取和结合功能的放射性碘化物和高锝酸盐摄取量的测量。
Nucl Med (Stuttg). 1972 Dec 30;11(4):338-51.
10
The behaviour of the thyroidal iodide trap after subtotal thyroidectomy for thyrotoxicosis and its implication for the T3-suppression test.甲状腺毒症行甲状腺次全切除术后甲状腺碘捕获的行为及其对T3抑制试验的意义。
Acta Endocrinol (Copenh). 1979 Sep;92(1):85-94. doi: 10.1530/acta.0.0920085.
引用本文的文献
1
Evaluation of Hot Nodules of Thyroid Gland Using Tc-99m Pertechnetate: a Novel Approach Using Quantitative Single-Photon Emission Computed Tomography/Computed Tomography.利用锝-99m高锝酸盐评估甲状腺热结节：一种使用定量单光子发射计算机断层扫描/计算机断层扫描的新方法。
Nucl Med Mol Imaging. 2018 Dec;52(6):468-472. doi: 10.1007/s13139-018-0554-5. Epub 2018 Nov 3.
2
Technetium-99 m in the diagnosis of thyrotoxicosis.锝-99m在甲状腺毒症诊断中的应用
Br Med J. 1972 Oct 28;4(5834):203-6. doi: 10.1136/bmj.4.5834.203.
3
The role of thyroid scanning in hyperthyroidism.甲状腺扫描在甲状腺功能亢进症中的作用。
Eur J Nucl Med. 1986;11(10):397-400. doi: 10.1007/BF00261404.
4
A strategy for thyroid function tests.甲状腺功能测试策略。
Br Med J. 1975 Aug 9;3(5979):350-2. doi: 10.1136/bmj.3.5979.350.
5
Tests of thyroid function in vivo.体内甲状腺功能测试。
J Clin Pathol. 1975 Mar;28(3):244-7. doi: 10.1136/jcp.28.3.244.
6
Thyroid imaging with iodine-125 and technetium-99m.
Eur J Nucl Med. 1979 Feb 1;4(1):37-41. doi: 10.1007/BF00257568.
本文引用的文献
1
PERTECHNETATE-99M LOCALIZATION IN MAN WITH APPLICATIONS TO THYROID SCANNING AND THE STUDY OF THYROID PHYSIOLOGY.99m锝高锝酸盐在人体中的定位及其在甲状腺扫描和甲状腺生理学研究中的应用
J Clin Endocrinol Metab. 1965 Aug;25:1067-76. doi: 10.1210/jcem-25-8-1067.
2
A diagnostic radioiodine uptake test in patients receiving antithyroid drug.
J Clin Endocrinol Metab. 1960 Dec;20:1601-7. doi: 10.1210/jcem-20-12-1601.
3
The iodide trapping and binding functions of the thyroid.甲状腺的碘捕获与结合功能。
J Clin Invest. 1955 Feb;34(2):186-204. doi: 10.1172/JCI103072.
4
Measurement of the uptake of 99mTc by the thyroid.
Br J Radiol. 1968 Dec;41(492):896-8. doi: 10.1259/0007-1285-41-492-896.
5
Thyroidal uptake and turnover of the pertechnetate ion in normal and hyperthyroid subjects.
J Clin Endocrinol Metab. 1968 Apr;28(4):575-81. doi: 10.1210/jcem-28-4-575.
6
The choice of a radioactive isotope for the investigation of thyroid disorders.用于甲状腺疾病检查的放射性同位素的选择。
Br J Radiol. 1968 Jan;41(481):20-5. doi: 10.1259/0007-1285-41-481-20.
7
Assessment of thyroid function and anatomy with technetium-99m as pertechnetate.
J Nucl Med. 1968 Jan;9(1):7-15.
8
99mTc-pertechnetate for measuring thyroid suppressibility.
J Nucl Med. 1971 Feb;12(2):51-4.
9
Development of thyroidal suppression by triiodothyronine during six months' treatment of thyrotoxicosis with antithyroid drugs.在用抗甲状腺药物治疗甲状腺毒症六个月期间，三碘甲状腺原氨酸引起的甲状腺抑制的发展情况。
J Clin Endocrinol Metab. 1967 Dec;27(12):1682-9. doi: 10.1210/jcem-27-12-1682.
10
Thyroidal suppression by triiodothyronine as a guide to duration of treatment of thyrotoxicosis with antithyroid drugs.用三碘甲状腺原氨酸进行甲状腺抑制作为抗甲状腺药物治疗甲状腺毒症疗程的指导
Lancet. 1966 Nov 12;2(7472):1041-4. doi: 10.1016/s0140-6736(66)92024-1.
Zotero 插件